Autocrine transforming growth factor β1 modulates the expression of integrin α5β1 in human colon carcinoma FET cells

D. Wang, G. H. Zhou, T. M. Birkenmeier, J. Gong, L. Sun, M. G. Brattain

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Transforming growth factor β (TGF-β) has been extensively studied as an exogenous agent that stimulates the expression of extracellular matrix proteins and their cell-surface integrin receptors in a variety of cell types. However, the recent demonstration of autocrine TGF-β growth effects in a number of cell types suggests that the steady-state expression of extracellular matrix and integrin proteins and their biological activity may also be under autocrine TGF-β control. Previously, we reported that repression of autocrine TGF-β1 activity by constitutive expression of a full-length TGF-β1 antisense cDNA led to abrogation of autocrine negative TGF-β and, as a result, increased tumorigenicity and anchorage-independent growth of a poorly tumorigenic, well-differentiated colon carcinoma cell line designated FET (Wu, S., Theodorescu, D., Kerbel, R. S., Willson, J. K. V., Mulder, K. M., Humphrey, L. E., and Brattain, M. G. (1992) J. Cell Biol. 116, 187-196). Consequently, we have used this model system to study the effects of repression of autocrine TGF-β1 activity on the expression of integrin α5β1 and integrin α5β1-mediated cell adhesion to fibronectin. The expression of the integrin α5 subunit was reduced in TGF-β1 antisense transfected FET cells at both mRNA and protein levels as determined by RNase protection assays and immunoprecipitation, respectively. Autocrine TGF-β1 had no effect on the transcription of integrin α5 and β1 subunits, indicating that autocrine TGF-β1 may regulate integrin α5β1 expression at the post-transcriptional level. The diminished expression of integrin α5β1 on the cell surface led to the reduced adhesion of TGF-β1 antisense transfected cells to fibronectin. This phenomenon could be reversed by treatment with exogenous TGF-β1.

Original languageEnglish (US)
Pages (from-to)14154-14159
Number of pages6
JournalJournal of Biological Chemistry
Volume270
Issue number23
DOIs
StatePublished - Jan 1 1995

Fingerprint

Transforming Growth Factors
Field effect transistors
Integrins
Colon
Carcinoma
Extracellular Matrix Proteins
Fibronectins
Cell adhesion
Cell Surface Receptors
Transcription
Ribonucleases
Growth
Bioactivity
Immunoprecipitation
Cell Adhesion
Assays
Proteins
Demonstrations
Adhesion
Complementary DNA

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Autocrine transforming growth factor β1 modulates the expression of integrin α5β1 in human colon carcinoma FET cells. / Wang, D.; Zhou, G. H.; Birkenmeier, T. M.; Gong, J.; Sun, L.; Brattain, M. G.

In: Journal of Biological Chemistry, Vol. 270, No. 23, 01.01.1995, p. 14154-14159.

Research output: Contribution to journalArticle

Wang, D. ; Zhou, G. H. ; Birkenmeier, T. M. ; Gong, J. ; Sun, L. ; Brattain, M. G. / Autocrine transforming growth factor β1 modulates the expression of integrin α5β1 in human colon carcinoma FET cells. In: Journal of Biological Chemistry. 1995 ; Vol. 270, No. 23. pp. 14154-14159.
@article{cd582de6cf6d4bbeb664ab16ee9da10f,
title = "Autocrine transforming growth factor β1 modulates the expression of integrin α5β1 in human colon carcinoma FET cells",
abstract = "Transforming growth factor β (TGF-β) has been extensively studied as an exogenous agent that stimulates the expression of extracellular matrix proteins and their cell-surface integrin receptors in a variety of cell types. However, the recent demonstration of autocrine TGF-β growth effects in a number of cell types suggests that the steady-state expression of extracellular matrix and integrin proteins and their biological activity may also be under autocrine TGF-β control. Previously, we reported that repression of autocrine TGF-β1 activity by constitutive expression of a full-length TGF-β1 antisense cDNA led to abrogation of autocrine negative TGF-β and, as a result, increased tumorigenicity and anchorage-independent growth of a poorly tumorigenic, well-differentiated colon carcinoma cell line designated FET (Wu, S., Theodorescu, D., Kerbel, R. S., Willson, J. K. V., Mulder, K. M., Humphrey, L. E., and Brattain, M. G. (1992) J. Cell Biol. 116, 187-196). Consequently, we have used this model system to study the effects of repression of autocrine TGF-β1 activity on the expression of integrin α5β1 and integrin α5β1-mediated cell adhesion to fibronectin. The expression of the integrin α5 subunit was reduced in TGF-β1 antisense transfected FET cells at both mRNA and protein levels as determined by RNase protection assays and immunoprecipitation, respectively. Autocrine TGF-β1 had no effect on the transcription of integrin α5 and β1 subunits, indicating that autocrine TGF-β1 may regulate integrin α5β1 expression at the post-transcriptional level. The diminished expression of integrin α5β1 on the cell surface led to the reduced adhesion of TGF-β1 antisense transfected cells to fibronectin. This phenomenon could be reversed by treatment with exogenous TGF-β1.",
author = "D. Wang and Zhou, {G. H.} and Birkenmeier, {T. M.} and J. Gong and L. Sun and Brattain, {M. G.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1074/jbc.270.23.14154",
language = "English (US)",
volume = "270",
pages = "14154--14159",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "23",

}

TY - JOUR

T1 - Autocrine transforming growth factor β1 modulates the expression of integrin α5β1 in human colon carcinoma FET cells

AU - Wang, D.

AU - Zhou, G. H.

AU - Birkenmeier, T. M.

AU - Gong, J.

AU - Sun, L.

AU - Brattain, M. G.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Transforming growth factor β (TGF-β) has been extensively studied as an exogenous agent that stimulates the expression of extracellular matrix proteins and their cell-surface integrin receptors in a variety of cell types. However, the recent demonstration of autocrine TGF-β growth effects in a number of cell types suggests that the steady-state expression of extracellular matrix and integrin proteins and their biological activity may also be under autocrine TGF-β control. Previously, we reported that repression of autocrine TGF-β1 activity by constitutive expression of a full-length TGF-β1 antisense cDNA led to abrogation of autocrine negative TGF-β and, as a result, increased tumorigenicity and anchorage-independent growth of a poorly tumorigenic, well-differentiated colon carcinoma cell line designated FET (Wu, S., Theodorescu, D., Kerbel, R. S., Willson, J. K. V., Mulder, K. M., Humphrey, L. E., and Brattain, M. G. (1992) J. Cell Biol. 116, 187-196). Consequently, we have used this model system to study the effects of repression of autocrine TGF-β1 activity on the expression of integrin α5β1 and integrin α5β1-mediated cell adhesion to fibronectin. The expression of the integrin α5 subunit was reduced in TGF-β1 antisense transfected FET cells at both mRNA and protein levels as determined by RNase protection assays and immunoprecipitation, respectively. Autocrine TGF-β1 had no effect on the transcription of integrin α5 and β1 subunits, indicating that autocrine TGF-β1 may regulate integrin α5β1 expression at the post-transcriptional level. The diminished expression of integrin α5β1 on the cell surface led to the reduced adhesion of TGF-β1 antisense transfected cells to fibronectin. This phenomenon could be reversed by treatment with exogenous TGF-β1.

AB - Transforming growth factor β (TGF-β) has been extensively studied as an exogenous agent that stimulates the expression of extracellular matrix proteins and their cell-surface integrin receptors in a variety of cell types. However, the recent demonstration of autocrine TGF-β growth effects in a number of cell types suggests that the steady-state expression of extracellular matrix and integrin proteins and their biological activity may also be under autocrine TGF-β control. Previously, we reported that repression of autocrine TGF-β1 activity by constitutive expression of a full-length TGF-β1 antisense cDNA led to abrogation of autocrine negative TGF-β and, as a result, increased tumorigenicity and anchorage-independent growth of a poorly tumorigenic, well-differentiated colon carcinoma cell line designated FET (Wu, S., Theodorescu, D., Kerbel, R. S., Willson, J. K. V., Mulder, K. M., Humphrey, L. E., and Brattain, M. G. (1992) J. Cell Biol. 116, 187-196). Consequently, we have used this model system to study the effects of repression of autocrine TGF-β1 activity on the expression of integrin α5β1 and integrin α5β1-mediated cell adhesion to fibronectin. The expression of the integrin α5 subunit was reduced in TGF-β1 antisense transfected FET cells at both mRNA and protein levels as determined by RNase protection assays and immunoprecipitation, respectively. Autocrine TGF-β1 had no effect on the transcription of integrin α5 and β1 subunits, indicating that autocrine TGF-β1 may regulate integrin α5β1 expression at the post-transcriptional level. The diminished expression of integrin α5β1 on the cell surface led to the reduced adhesion of TGF-β1 antisense transfected cells to fibronectin. This phenomenon could be reversed by treatment with exogenous TGF-β1.

UR - http://www.scopus.com/inward/record.url?scp=0029017485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029017485&partnerID=8YFLogxK

U2 - 10.1074/jbc.270.23.14154

DO - 10.1074/jbc.270.23.14154

M3 - Article

C2 - 7539800

AN - SCOPUS:0029017485

VL - 270

SP - 14154

EP - 14159

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 23

ER -